Home › Ischemic Stroke › NCT06148285

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Recovery

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Age 18 years and above
* Ischemic stroke proven on neuroimaging
* Within 7-30 days post-stroke on day 1 of treatment
* Admitted to Touro Inpatient Rehab Facility

Exclusion Criteria:

* Pre-stroke modified Rankin Scale Score \>2
* Parenchymal hemorrhagic transformation (PH1 or PH2)
* Receptive aphasia such that recommendations for preventative measures to mitigate barotrauma cannot be followed
* History of recurrent and unprovoked seizures requiring a change in management in the last 3 months to control seizures
* Pulmonary disease requiring supplemental oxygen or daily respiratory medication management (metered dose inhalers, nebulized treatment or steroids)

About the study

This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.

What is being tested

• Hyperbaric Oxygen Therapy (device)

Sponsor: LCMC Health · Participants: 120 · Started: May 24, 2022

Contact the study team

• Lawrence Matarutse · Phone: 504-962-6419
• Sheryl Martin-Schild, MD, PhD · Phone: 504-982-3278

Official record on ClinicalTrials.gov — NCT06148285

Locations in the U.S.

Conditions

• Ischemic Stroke

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.